Oncopeptides AbOMXSTO: ONCO

Oncopeptides (Q1 Update): Strong Quarterly Growth and Decreased Costs

· Issued by Oncopeptides Ab

Redeye’s analyst just published a Research Update on Oncopeptides.

Click here to read the article

Make sure to add Oncopeptides to your Watchlist at Redeye and our analysts will notify you if anything relevant happens regarding your companies.

This is a press release from Redeye - Nordic Growth. www.redeye.se

Attachments


Oncopeptides (Q1 Update): Strong Quarterly Growth and Decreased Costs

© Modular Finance, source Nordic Press Releases

Earlier from Oncopeptides Ab

All Oncopeptides Ab news releases